BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 12269862)

  • 21. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamotrigine--an update.
    Brodie MJ
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S6-9. PubMed ID: 8951213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
    Greenhalgh J; Weston J; Dundar Y; Nevitt SJ; Marson AG
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD007286. PubMed ID: 32343399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
    Heller AJ; Chesterman P; Elwes RD; Crawford P; Chadwick D; Johnson AL; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):44-50. PubMed ID: 7823066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of valproate monotherapy in the treatment of generalized tonic-clonic seizures.
    Wilder BJ; Rangel RJ
    Am J Med; 1988 Jan; 84(1A):7-13. PubMed ID: 3146225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
    Battino D; Tomson T; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Epilepsia; 2013 Sep; 54(9):1621-7. PubMed ID: 23848605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice.
    Verrotti A; Lattanzi S; Brigo F; Zaccara G
    Epilepsy Behav; 2020 Mar; 104(Pt A):106939. PubMed ID: 32058303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of drugs for the treatment of epilepsy.
    Mattson RH
    Semin Neurol; 1990 Dec; 10(4):406-13. PubMed ID: 2287835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Established antiepileptic drugs.
    Perucca E
    Baillieres Clin Neurol; 1996 Dec; 5(4):693-722. PubMed ID: 9068876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.